packageIrinotecan
irinotecan
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Irinotecan is a topoisomerase I inhibitor used as an anticancer medicine, mainly for colorectal and pancreatic cancers and also for several other cancers such as lung, breast, stomach and brain tumours. It remains in use, is authorised in the European Union, and is included on the WHO list of essential medicines.
Summary written by glm-5.3-flash from Wikidata Q412197 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | irinotecan |
| ATC codes: | L01CE02, L01XX19 |
| DrugBank: | DB00762 |
| PubChem CID: | 60838 |
| ChEBI: | 80630 |
| Wikidata: | Q412197 |
| formula: | C33H38N4O6 |
| molar mass: | 586.689 g/mol (PubChem CID 60838) |
| logP: | 3 (Drugs.Common 25.09, not verified) |
Metabolites
SN38 | SN-38 | 392.411 g/mol (pubchem) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |
Contents
| Name | Description |
|---|---|
| metabolite: SN-38 |